Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Mar 20, 2025 | (Q2)Sep 20, 2024 | (Q1)Jun 20, 2024 | (FY)Mar 20, 2024 | (Q4)Mar 20, 2024 | (Q3)Dec 20, 2023 | (Q2)Sep 20, 2023 | (Q1)Jun 20, 2023 | (FY)Mar 20, 2023 | (Q4)Mar 20, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.32%45.11B | 5.61%11.22B | 0.70%11.14B | 11.43%44.09B | 5.32%10.02B | 13.46%12.38B | 11.97%10.63B | 14.63%11.06B | 7.22%39.57B | 12.03%9.51B |
| Cost of revenue | 3.96%27.36B | 7.51%6.8B | -3.01%6.66B | 2.77%26.32B | -5.26%6.03B | 1.62%7.09B | 4.68%6.33B | 10.43%6.87B | 10.80%25.61B | 14.40%6.36B |
| Gross profit | -0.11%17.76B | 2.84%4.42B | 6.77%4.48B | 27.31%17.77B | 26.70%3.99B | 34.48%5.29B | 24.70%4.3B | 22.27%4.19B | 1.21%13.96B | 7.51%3.15B |
| Operating expense | 4.00%10.85B | 5.61%2.58B | 1.86%2.84B | 5.29%10.44B | -0.75%2.37B | 14.36%2.84B | 1.41%2.44B | 5.76%2.79B | 1.71%9.91B | 5.67%2.39B |
| Staff costs | 2.98%4.18B | 3.73%1.06B | 2.35%1.05B | -0.05%4.06B | -2.62%1B | 1.30%1.01B | 0.69%1.02B | 0.49%1.02B | 1.32%4.06B | 4.46%1.03B |
| Selling and administrative expenses | 0.71%2.28B | 3.70%561M | -5.21%582M | 0.85%2.27B | -4.80%496M | 2.16%614M | -0.73%541M | 6.04%614M | -1.71%2.25B | 0.77%521M |
| -General and administrative expense | 0.71%2.28B | 3.70%561M | -5.21%582M | 0.85%2.27B | -4.80%496M | 2.16%614M | -0.73%541M | 6.04%614M | -1.71%2.25B | 0.77%521M |
| Other operating expenses | 6.80%4.4B | 8.95%962M | 5.19%1.22B | 14.05%4.12B | 4.08%867M | 37.59%1.21B | 3.64%883M | 10.72%1.16B | 4.43%3.61B | 10.62%833M |
| Operating profit | -5.94%6.9B | -0.81%1.84B | 16.55%1.63B | 81.25%7.34B | 112.29%1.62B | 68.70%2.46B | 78.86%1.85B | 77.47%1.4B | 0.00%4.05B | 13.67%765M |
| Net non-operating interest income (expenses) | 40.00%7M | 50.00%3M | 0.00%-3M | 25.00%5M | 200.00%3M | -25.00%3M | 100.00%2M | -50.00%-3M | -33.33%4M | -50.00%1M |
| Non-operating interest income | 21.43%17M | 33.33%4M | 0.00%3M | 7.69%14M | 33.33%4M | 0.00%4M | 0.00%3M | 0.00%3M | 0.00%13M | 0.00%3M |
| Non-operating interest expense | 66.67%5M | 0.00%1M | --1M | -25.00%3M | -50.00%1M | --1M | -50.00%1M | --0 | 0.00%4M | 100.00%2M |
| Total other finance cost | -16.67%5M | --0 | -16.67%5M | 20.00%6M | --0 | --0 | --0 | 20.00%6M | 66.67%5M | --0 |
| Net investment income | 14.81%62M | 12.00%28M | 100.00%8M | 80.00%54M | 0 | 127.27%25M | 78.57%25M | 0.00%4M | 7.14%30M | 0.00%1M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 40.00%14M | 50.00%6M | 25.00%5M | 176.92%10M | 90.48%-2M | 4M | 100.00%4M | -33.33%4M | 90.15%-13M | 84.09%-21M |
| Less:Other special charges | -40.00%-14M | -50.00%-6M | -25.00%-5M | 16.67%-10M | 150.00%2M | ---4M | -100.00%-4M | 33.33%-4M | -200.00%-12M | ---4M |
| Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -81.62%25M | ---- |
| Other non-operating income (expenses) | 13.16%86M | -71.43%4M | 29.41%22M | 26.67%76M | 33.33%24M | 23.53%21M | 7.69%14M | 41.67%17M | 147.24%60M | 162.07%18M |
| Income before tax | -5.48%7.07B | -1.16%1.88B | 17.09%1.67B | 81.22%7.48B | 115.71%1.65B | 68.53%2.51B | 78.00%1.9B | 76.21%1.42B | 8.07%4.13B | 48.35%764M |
| Income tax | -5.13%2.17B | -11.33%595M | 45.79%519M | 74.60%2.28B | 107.63%490M | 61.05%765M | 101.50%671M | 35.36%356M | 8.65%1.31B | 29.67%236M |
| Net income | -5.64%4.9B | 4.47%1.29B | 7.41%1.15B | 84.35%5.2B | 119.92%1.16B | 71.77%1.74B | 67.57%1.23B | 95.96%1.07B | 7.76%2.82B | 58.26%527M |
| Net income continuous operations | -5.64%4.9B | 4.39%1.28B | 7.50%1.15B | 84.29%5.2B | 119.32%1.16B | 72.04%1.74B | 67.35%1.23B | 95.96%1.07B | 7.80%2.82B | 58.56%528M |
| Noncontrolling interests | -12.82%68M | -26.32%14M | -29.17%17M | 2.63%78M | 4.55%23M | -29.41%12M | 11.76%19M | 20.00%24M | -8.43%76M | -8.33%22M |
| Net income attributable to the company | -5.53%4.83B | 5.04%1.27B | 8.16%1.13B | 86.58%5.12B | 124.51%1.14B | 73.67%1.73B | 68.52%1.21B | 99.24%1.04B | 8.34%2.74B | 64.29%506M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -5.53%4.83B | 5.04%1.27B | 8.16%1.13B | 86.58%5.12B | 124.51%1.14B | 73.67%1.73B | 68.52%1.21B | 99.24%1.04B | 8.34%2.74B | 64.29%506M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -1.61%299.64 | 12.04%78.81 | 15.47%69.92 | 91.05%304.53 | 141.06%70.8 | 77.74%102.84 | 68.52%70.34 | 98.98%60.55 | 8.20%159.4 | 63.62%29.37 |
| Diluted earnings per share | -1.61%299.64 | 12.13%78.7955 | 15.47%69.92 | 91.05%304.53 | 139.98%70.4821 | 77.74%102.84 | 68.35%70.2712 | 98.98%60.55 | 8.20%159.4 | 63.94%29.37 |
| Dividend per share | 0.00%150 | 0.00%50 | 0 | 200.00%150 | 300.00%100 | 0 | 100.00%50 | 0 | 0.00%50 | 0.00%25 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |